Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 8INDUSTRY 5INDIV 2OTHER_GOV 1

Study Type

Interventional 2

Sponsor

Conditions

Neoplasms 8Barrett Esophagus 5Myasthenia Gravis 4Breast Neoplasms 4Leiomyoma 3Carcinoma, Hepatocellular 3Pancreatic Neoplasms 2Multiple Myeloma 2Lymphoma, Follicular 2Lung Neoplasms 2Lipoma 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma in Situ 2Warts 1Vaginosis, Bacterial 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Syphilis 1Sexually Transmitted Diseases 1Retroperitoneal liposarcoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pilonidal Sinus 1Papillomavirus Infections 1Overweight 1Ovarian Neoplasms 1Osteosarcoma 1

Interventions

Microbial Collagenase 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDIV × Lipoma × Clear all
NCT02249052 2017-02-23

Double Blind Study to Evaluate the Efficacy of Collagenase Histolyticum in the Treatment of Lipoma

Gerut, Zachary, M.D.

Phase 2 Completed
19 enrolled 11 charts

Lipoma

NCT01613313 2016-10-06

A Dose Escalation Study Using Collagenase Clostridium Histolyticum in the Treatment of Lipoma

Gerut, Zachary, M.D.

Phase 2 Completed
14 enrolled 8 charts

Lipoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡